CLINICAL_TRIALS
research
· 2025-09-04
Clinical Trial Update: A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer [Phase 2]
Summary
A Phase 2 study evaluating Botensilimab and Balstilimab for metastatic colorectal cancer is currently active but not recruiting, sponsored by Agenus Inc. This u…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Agenus Inc. | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING